Synthesis, anti-diabetic evaluation and molecular docking studies of 4-(1-aryl-1H-1, 2, 3-triazol-4-yl)-1,4-dihydropyridine derivatives as novel 11-β hydroxysteroid dehydrogenase-1 (11β-HSD1) inhibitors

This publication has 27 references indexed in Scilit:

• Selective Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1 for Patients With Metabolic Syndrome
  Diabetes, 2009
• Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes
  Nature Reviews Molecular Cell Biology, 2008
• Adipocytes as regulators of energy balance and glucose homeostasis
  Nature, 2006
• NEW 4-ARYL-1,4-DIHYDROPYRIDINES AND 4-ARYLPYRIDINES AS P-GLYCOPROTEIN INHIBITORS
  Drug Metabolism and Disposition, 2005
• Synthesis and calcium antagonist activity of 1,4-dihydropyridines containing phenylaminoimidazolyl substituents
  Il Farmaco, 2003
• A Transgenic Model of Visceral Obesity and the Metabolic Syndrome
  Science, 2001
• Permanently Charged Chiral 1,4-Dihydropyridines: Molecular Probes of L-Type Calcium Channels. Synthesis and Pharmacological Characterization of Methyl (ω-Trimethylalkylammonium) 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5- pyridinedicarboxylate Iodide, Calcium Channel Antagonists
  Journal of Medicinal Chemistry, 2000
• Dihydropyridine Calcium Antagonist‐Induced Modulation of Endothelial Function: A Review
  Cardiovascular Drug Reviews, 1999
• Interaction of the antihypertensive drug felodipine with calmodulin
  Nature, 1981
• Synthesis of new water-soluble dihydropyridine vasodilators.
  Chemical and Pharmaceutical Bulletin, 1979